Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Michael A Welch

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Functional Neurology|January 6, 2004
"Ottorino Rossi" Award 2003K Michael A Welch
Current Opinion in Neurology|June 5, 2002
Chronic daily headache: nosology and pathophysiologyK Michael A Welch, Peter J Goadsby
The Lancet. Neurology|August 20, 2005
Relation between migraine and strokeMarie-Germaine Bousser, K Michael A Welch
Stroke|November 9, 2017
Association of Osteopontin, Neopterin, and Myeloperoxidase With Stroke Risk in Patients With Prior Stroke or Transient Ischemic Attacks: Results of an Analysis of 13 Biomarkers From the Stroke Prevention by Aggressive Reduction in Cholesterol Levels TrialPeter Ganz, Pierre Amarenco, Larry B Goldstein, et al.
European Neurology|June 24, 2025
Fourteen Biomarkers and Subsequent Disability in Patients with Stroke Recurrence: Results from the SPARCL TrialElena Meseguer, Peter Ganz, Weihang Bao, et al.
Brain Research. Molecular Brain Research|June 23, 2004
Response of the brain to oligemia: gene expression, c-Fos, and Nrf2 localizationChristopher S Liverman, Lisa Cui, Chi Yong, et al.
Cerebrovascular Diseases (Basel, Switzerland)|May 26, 2004
Statins for secondary stroke prevention in patients without known coronary heart disease: the jury is still outLarry B Goldstein, Pierre Amarenco, Julien Bogousslavsky, et al.
Stroke|July 12, 2008
Relative effects of statin therapy on stroke and cardiovascular events in men and women: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) StudyLarry B Goldstein, Pierre Amarenco, Marian Lamonte, et al.
Neuropeptides|June 7, 2005
Ovarian steroids regulate neuropeptides in the trigeminal ganglionVeena Puri, Lisa Cui, Christopher S Liverman, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|March 4, 2014
Prediction of major vascular events after stroke: the stroke prevention by aggressive reduction in cholesterol levels trialBruce Ovbiagele, Larry B Goldstein, Pierre Amarenco, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Functional Neurology|January 6, 2004
"Ottorino Rossi" Award 2003K Michael A Welch
Current Opinion in Neurology|June 5, 2002
Chronic daily headache: nosology and pathophysiologyK Michael A Welch, Peter J Goadsby
The Lancet. Neurology|August 20, 2005
Relation between migraine and strokeMarie-Germaine Bousser, K Michael A Welch
Stroke|November 9, 2017
Association of Osteopontin, Neopterin, and Myeloperoxidase With Stroke Risk in Patients With Prior Stroke or Transient Ischemic Attacks: Results of an Analysis of 13 Biomarkers From the Stroke Prevention by Aggressive Reduction in Cholesterol Levels TrialPeter Ganz, Pierre Amarenco, Larry B Goldstein, et al.
European Neurology|June 24, 2025
Fourteen Biomarkers and Subsequent Disability in Patients with Stroke Recurrence: Results from the SPARCL TrialElena Meseguer, Peter Ganz, Weihang Bao, et al.
Brain Research. Molecular Brain Research|June 23, 2004
Response of the brain to oligemia: gene expression, c-Fos, and Nrf2 localizationChristopher S Liverman, Lisa Cui, Chi Yong, et al.
Cerebrovascular Diseases (Basel, Switzerland)|May 26, 2004
Statins for secondary stroke prevention in patients without known coronary heart disease: the jury is still outLarry B Goldstein, Pierre Amarenco, Julien Bogousslavsky, et al.
Stroke|July 12, 2008
Relative effects of statin therapy on stroke and cardiovascular events in men and women: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) StudyLarry B Goldstein, Pierre Amarenco, Marian Lamonte, et al.
Neuropeptides|June 7, 2005
Ovarian steroids regulate neuropeptides in the trigeminal ganglionVeena Puri, Lisa Cui, Christopher S Liverman, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|March 4, 2014
Prediction of major vascular events after stroke: the stroke prevention by aggressive reduction in cholesterol levels trialBruce Ovbiagele, Larry B Goldstein, Pierre Amarenco, et al.
Pageof 2